Literature DB >> 23465840

HLA Class I and II study in a mestizo family with high incidence of autoimmune disease.

Alicia Habegger de Sorrentino1, Marcela Young, Karina Marinic, Patricia Fabiana Motta, Carlos Baruzzo.   

Abstract

There are many factors that influence the pathogenesis of autoimmune disease of which host genetic factors play an important role. The aim of this study was to investigate the HLA Class I and II genes in a family with a high incidence of AID to establish whether they contribute to the development of these disease. Four of them had been diagnosed with SLE and one with AHA. The patients with SLE showed the presence of HLA-A*02 B*40 DRB1*04:07 DQB1*03:02 haplotype with a high statistical significance. This haplotype was not present in the healthy individuals and in the patient with AHA, although the DRB1*04:07 DQB1*03:02 haplotype (carried by both parents) was found in the AHA patients and one of the healthy individuals. We must consider how HLA Class I in linkage disequilibrium with HLA Class II may be involved in susceptibility or in the development of SLE. An extensive study in this population should be conducted to establish the true participation of the HLA Class I region.
Copyright © 2012 Elsevier España, S.L. All rights reserved.

Entities:  

Keywords:  Antígenos leucocitarios humanos Clase I y II; Autoimmune disease; Enfermedad autoinmunitaria; Familia mestiza; Genetics; Genética; Human leukocyte antigen Class I and II; Lupus eritematoso sistémico; Mestizo family; Systemic lupus erithematous

Mesh:

Year:  2013        PMID: 23465840     DOI: 10.1016/j.reuma.2012.11.004

Source DB:  PubMed          Journal:  Reumatol Clin        ISSN: 1699-258X


  1 in total

1.  Relevance of HLA gene polymorphisms in Romanian patients with chronic renal insufficiency undergoing renal transplantation.

Authors:  Ion Mărunţelu; Bogdan Mihai Cristea; Secil Omer; Carmen Monica Preda; Ileana Constantinescu
Journal:  J Clin Lab Anal       Date:  2021-10-27       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.